Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECa 233 Centella asiatica extract for healing after Er:YAG 2940 nm laser
TCTR20180927001Phase 2Active, not recruiting
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Sep 2018
- Countries
- 1
01
Overview
A Phase 2 trial of ECa 233 in cutaneous wound, sponsored by King Chulalongkorn Memorial Hospital. Started Sep 2018; status: active, not recruiting.
02
Drugs
ECa 233
03
Conditions
cutaneous wound
Beyond the preview
Go deeper on TCTR20180927001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180927001.